[1]
“Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial”, PPCR, vol. 2, no. 2, Nov. 2016, Accessed: Nov. 27, 2024. [Online]. Available: https://journal.ppcr.org/index.php/ppcrjournal/article/view/44